Narrow Results By
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
https://policybase.cma.ca/link/policy1950
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs
- Policy Type
- Parliamentary submission
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs
Documents
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
https://policybase.cma.ca/link/policy10382
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
https://policybase.cma.ca/link/policy10437
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
https://policybase.cma.ca/link/policy10631
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
https://policybase.cma.ca/link/policy10702
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
https://policybase.cma.ca/link/policy11035
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
https://policybase.cma.ca/link/policy11125
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
https://policybase.cma.ca/link/policy11129
- Date
- 2014-05-15
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
The Health risks and harms associated with the use of marijuana
https://policybase.cma.ca/link/policy11138
Bill C-17 An Act to amend the Food and Drugs Act
https://policybase.cma.ca/link/policy11196
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11297
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11519
National pharmacare in Canada: Getting there from here
https://policybase.cma.ca/link/policy11959
CMA submission to the study of Bill C-37
https://policybase.cma.ca/link/policy13617
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
https://policybase.cma.ca/link/policy13641
- Date
- 2017-04-07
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-45: The Cannabis Act
https://policybase.cma.ca/link/policy13723
Canada’s lower-risk cannabis use guidelines (LRCUG)
https://policybase.cma.ca/link/policy13726
Bill C-45: The Cannabis Act
https://policybase.cma.ca/link/policy13861
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
https://policybase.cma.ca/link/policy13918
- Date
- 2018-02-15
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety